Rothschild & Co Asset Management US’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.67M | Sell |
153,294
-1,188
| -0.8% | -$13K | 0.03% | 229 |
|
|
2022
Q3 | $1.3M | Sell |
154,482
-212,635
| -58% | -$1.79M | 0.02% | 239 |
|
|
2022
Q2 | $2.9M | Sell |
367,117
-12,009
| -3% | -$95K | 0.04% | 224 |
|
|
2022
Q1 | $8.98M | Sell |
379,126
-111,898
| -23% | -$2.65M | 0.11% | 148 |
|
|
2021
Q4 | $16.8M | Buy |
491,024
+273,541
| +126% | +$9.36M | 0.2% | 126 |
|
|
2021
Q3 | $3.85M | Sell |
217,483
-170,745
| -44% | -$3.03M | 0.05% | 228 |
|
|
2021
Q2 | $17.4M | Sell |
388,228
-46,021
| -11% | -$2.07M | 0.21% | 138 |
|
|
2021
Q1 | $11.2M | Buy |
+434,249
| New | +$11.2M | 0.14% | 184 |
|